AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 26-50/117
ABCIXIMAB BENEFIT IN CORONARY INTERVENTION HAS NO GENDER BIAS - RESULTS OF EPIC, EPILOG AND CAPTURE TRIALS
Authors: KEREIAKES DJ LINCOFF AM SIMOONS ML DEBOER MJ TCHENG JE VAHANIAN A ANDERSON KM CABOT CF CALIFF RM
Citation: Dj. Kereiakes et al., ABCIXIMAB BENEFIT IN CORONARY INTERVENTION HAS NO GENDER BIAS - RESULTS OF EPIC, EPILOG AND CAPTURE TRIALS, The American journal of cardiology, 82, 1998, pp. 95-95
GP IIB IIIA BLOCKADE DURING CORONARY INTERVENTION FOR UNSTABLE ANGINA- LONGER IS NOT BETTER/
Authors: KEREIAKES DJ LINCOFF AM TCHENG J TOPOL EJ
Citation: Dj. Kereiakes et al., GP IIB IIIA BLOCKADE DURING CORONARY INTERVENTION FOR UNSTABLE ANGINA- LONGER IS NOT BETTER/, The American journal of cardiology, 82, 1998, pp. 95-95
PLATELET GLYCOPROTEIN IIB IIA RECEPTOR BLOCKADE WITH ABCIXIMAB REDUCES ISCHEMIC COMPLICATIONS IN PATIENTS UNDERGOING DIRECTIONAL CORONARY ATHERECTOMY/
Authors: GHAFFARI S KEREIAKES DJ LINCOFF AM KELLY TA TIMMIS GC KLEIMAN NS FERGUSON JJ MILLER DP CALIFF RA TOPOL EJ
Citation: S. Ghaffari et al., PLATELET GLYCOPROTEIN IIB IIA RECEPTOR BLOCKADE WITH ABCIXIMAB REDUCES ISCHEMIC COMPLICATIONS IN PATIENTS UNDERGOING DIRECTIONAL CORONARY ATHERECTOMY/, The American journal of cardiology, 82(1), 1998, pp. 7-12
GLYCOPROTEIN IIB IIIA INHIBITORS IN ACUTE CORONARY SYNDROMES - PATHOPHYSIOLOGIC FOUNDATION AND CLINICAL FINDINGS/
Authors: KLEIMAN NS LINCOFF AM OHMAN EM HARRINGTON RA
Citation: Ns. Kleiman et al., GLYCOPROTEIN IIB IIIA INHIBITORS IN ACUTE CORONARY SYNDROMES - PATHOPHYSIOLOGIC FOUNDATION AND CLINICAL FINDINGS/, The American heart journal, 136(4), 1998, pp. 32-42
ANTITHROMBOTIC THERAPY WITH INTRACORONARY STENTING
Authors: STEINHUBL SR LINCOFF AM
Citation: Sr. Steinhubl et Am. Lincoff, ANTITHROMBOTIC THERAPY WITH INTRACORONARY STENTING, HEART, 78, 1997, pp. 21-23
EVIDENCE FOR PREVENTION OF DEATH AND MYOCARDIAL-INFARCTION WITH PLATELET MEMBRANE GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE BY ABCIXIMAB (C7E3 FAB) AMONG PATIENTS WITH UNSTABLE ANGINA UNDERGOING PERCUTANEOUS CORONARY REVASCULARIZATION/
Authors: LINCOFF AM CALIFF RM ANDERSON KM WEISMAN HF AGUIRRE FV KLEIMAN NS HARRINGTON RA TOPOL EJ
Citation: Am. Lincoff et al., EVIDENCE FOR PREVENTION OF DEATH AND MYOCARDIAL-INFARCTION WITH PLATELET MEMBRANE GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE BY ABCIXIMAB (C7E3 FAB) AMONG PATIENTS WITH UNSTABLE ANGINA UNDERGOING PERCUTANEOUS CORONARY REVASCULARIZATION/, Journal of the American College of Cardiology, 30(1), 1997, pp. 149-156
SUSTAINED LOCAL-DELIVERY OF DEXAMETHASONE BY A NOVEL INTRAVASCULAR ELUTING STENT TO PREVENT RESTENOSIS IN THE PORCINE CORONARY INJURY MODEL
Authors: LINCOFF AM FURST JG ELLIS SG TUCH RJ TOPOL EJ
Citation: Am. Lincoff et al., SUSTAINED LOCAL-DELIVERY OF DEXAMETHASONE BY A NOVEL INTRAVASCULAR ELUTING STENT TO PREVENT RESTENOSIS IN THE PORCINE CORONARY INJURY MODEL, Journal of the American College of Cardiology, 29(4), 1997, pp. 808-816
USE OF VERY LATE ANTIGEN-4 (VLA-4) INTEGRIN BINDING BLOCKADE WITH CONNECTING SEGMENT-1 PEPTIDE IN PREVENTION OF RESTENOSIS AFTER BALLOON ANGIOPLASTY IN THE RABBIT ATHEROSCLEROTIC MODEL
Authors: SILVER MJ SMULL DL FORUDI F BUCKNELL KA TOPOL EJ LINCOFF AM
Citation: Mj. Silver et al., USE OF VERY LATE ANTIGEN-4 (VLA-4) INTEGRIN BINDING BLOCKADE WITH CONNECTING SEGMENT-1 PEPTIDE IN PREVENTION OF RESTENOSIS AFTER BALLOON ANGIOPLASTY IN THE RABBIT ATHEROSCLEROTIC MODEL, Journal of the American College of Cardiology, 29(2), 1997, pp. 3993-3993
LOCALLY DELIVERED VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) DOES NOT INHIBIT NEOINTIMAL PROLIFERATION IN THE PORCINE RESTENOSIS MODEL
Authors: BELLI G ECCLESTON DS HORRIGAN MC FURST JG LINCOFF AM TOPOL EJ
Citation: G. Belli et al., LOCALLY DELIVERED VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) DOES NOT INHIBIT NEOINTIMAL PROLIFERATION IN THE PORCINE RESTENOSIS MODEL, Journal of the American College of Cardiology, 29(2), 1997, pp. 7016-7016
REDUCING THE RISK OF PERCUTANEOUS INTERVENTION AFTER CORONARY-BYPASS SURGERY - BENEFICIAL-EFFECTS OF ABCIXIMAB TREATMENT
Authors: TCHENG JE ANDERSON K TARDIFF BE CABOT CF LINCOFF AM CALIFF RM TOPOL EJ
Citation: Je. Tcheng et al., REDUCING THE RISK OF PERCUTANEOUS INTERVENTION AFTER CORONARY-BYPASS SURGERY - BENEFICIAL-EFFECTS OF ABCIXIMAB TREATMENT, Journal of the American College of Cardiology, 29(2), 1997, pp. 7395-7395
ABCIXIMAB (C7E3 FAB, REOPRO) WITH REDUCED HEPARIN DOSING DURING CORONARY INTERVENTION - FINAL RESULTS OF THE EPILOG TRIAL
Authors: LINCOFF AM TCHENG JE CALIFF RM CABOT CF MILLER DP BOOTH JE MONTAGUE EA ANDERSON KM TOPOL EJ
Citation: Am. Lincoff et al., ABCIXIMAB (C7E3 FAB, REOPRO) WITH REDUCED HEPARIN DOSING DURING CORONARY INTERVENTION - FINAL RESULTS OF THE EPILOG TRIAL, Journal of the American College of Cardiology, 29(2), 1997, pp. 7396-7396
INCIDENCE AND CLINICAL OUTCOME OF ABRUPT VESSEL CLOSURE AMONG PATIENTS RECEIVING ABCIXIMAB DURING HIGH-RISK PERCUTANEOUS CORONARY INTERVENTION - EPIC TRIAL RESULTS
Authors: AGUIRRE FV TOPOL EJ LEIMBERGER J KLEIMAN N LINCOFF AM DONOHUE TJ CALIFF RM
Citation: Fv. Aguirre et al., INCIDENCE AND CLINICAL OUTCOME OF ABRUPT VESSEL CLOSURE AMONG PATIENTS RECEIVING ABCIXIMAB DURING HIGH-RISK PERCUTANEOUS CORONARY INTERVENTION - EPIC TRIAL RESULTS, Journal of the American College of Cardiology, 29(2), 1997, pp. 8011-8011
IS THERE A DIFFERENTIAL BENEFIT OF REOPRO DURING PTCA FOR PATIENTS WITH CERTAIN LESION TYPES
Authors: ELLIS S LINCOFF AM TCHENG JE MILLER DP BOOTH JE CALIFF RM TOPOL E
Citation: S. Ellis et al., IS THERE A DIFFERENTIAL BENEFIT OF REOPRO DURING PTCA FOR PATIENTS WITH CERTAIN LESION TYPES, Journal of the American College of Cardiology, 29(2), 1997, pp. 8012-8012
WHAT PREDICTS CONTRAST NEPHROPATHY AFTER CORONARY INTERVENTION - INSIGHTS FROM THE IMPACT-II TRIAL
Authors: THEL MC DAVIDSON CJ AGUIRRE FV PECK SL TCHENG JE LINCOFF AM TOPOL EJ CALIFF RM
Citation: Mc. Thel et al., WHAT PREDICTS CONTRAST NEPHROPATHY AFTER CORONARY INTERVENTION - INSIGHTS FROM THE IMPACT-II TRIAL, Journal of the American College of Cardiology, 29(2), 1997, pp. 8210-8210
BENEFITS OF ABCIXIMAB ACCRUE IN THE FULL SPECTRUM OF CORONARY INTERVENTIONAL PATIENTS - INSIGHTS FROM THE EPILOG TRIAL
Authors: TCHENG JE LINCOFF AM MILLER DP BOOTH JE RUND MM CABOT CF WEISMAN HF CALIFF RM TOPOL EJ
Citation: Je. Tcheng et al., BENEFITS OF ABCIXIMAB ACCRUE IN THE FULL SPECTRUM OF CORONARY INTERVENTIONAL PATIENTS - INSIGHTS FROM THE EPILOG TRIAL, Journal of the American College of Cardiology, 29(2), 1997, pp. 9931-9931
BLEEDING WITH CORONARY-ARTERY BYPASS-SURGERY (CABG) IN PATIENTS TREATED WITH A PLATELET GLYCOPROTEIN IIB IIIA INHIBITOR/
Authors: TARDIFF BE TCHENG JE PECK S LINCOFF AM HARRINGTON RA CALIFF RM TOPOL EJ
Citation: Be. Tardiff et al., BLEEDING WITH CORONARY-ARTERY BYPASS-SURGERY (CABG) IN PATIENTS TREATED WITH A PLATELET GLYCOPROTEIN IIB IIIA INHIBITOR/, Journal of the American College of Cardiology, 29(2), 1997, pp. 52128-52128
ECONOMIC-ASSESSMENT OF PLATELET GLYCOPROTEIN IIB IIA RECEPTOR BLOCKADE DURING CORONARY INTERVENTION IN THE EPILOG TRIAL/
Authors: LINCOFF AM MARK DB CALIFF RM TCHENG JE ELLIS SG DAVIDSONRAY L ANDERSON KM STONER GL TOPOL EJ
Citation: Am. Lincoff et al., ECONOMIC-ASSESSMENT OF PLATELET GLYCOPROTEIN IIB IIA RECEPTOR BLOCKADE DURING CORONARY INTERVENTION IN THE EPILOG TRIAL/, Journal of the American College of Cardiology, 29(2), 1997, pp. 97484-97484
USE OF ABCIXIMAB (REOPRO(R)) IS NOT ASSOCIATED WITH AN INCREASE IN THE RISK OF STROKE - OVERVIEW OF 3 RANDOMIZED TRIALS
Authors: DECKERS J CALIFF RM TOPOL EJ LINCOFF AM TCHENG JE SIMOONS ML
Citation: J. Deckers et al., USE OF ABCIXIMAB (REOPRO(R)) IS NOT ASSOCIATED WITH AN INCREASE IN THE RISK OF STROKE - OVERVIEW OF 3 RANDOMIZED TRIALS, Journal of the American College of Cardiology, 29(2), 1997, pp. 97489-97489
LOCAL-DELIVERY OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) TO REDUCE NEOINTIMAL PROLIFERATION IN THE PORCINE CORONARY BALLOON INJURY MODEL
Authors: STEINHUBL SR BELLI G WU CJ YOON J FURST J GALLUPI GR KAPLAN AV TOPOL EJ LINCOFF AM
Citation: Sr. Steinhubl et al., LOCAL-DELIVERY OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) TO REDUCE NEOINTIMAL PROLIFERATION IN THE PORCINE CORONARY BALLOON INJURY MODEL, Journal of the American College of Cardiology, 29(2), 1997, pp. 97557-97557
CATHETER-BASED DRUG-DELIVERY FOR RESTENOSIS
Authors: ECCLESTON DS LINCOFF AM
Citation: Ds. Eccleston et Am. Lincoff, CATHETER-BASED DRUG-DELIVERY FOR RESTENOSIS, Advanced drug delivery reviews, 24(1), 1997, pp. 31-43
RANDOMIZED PLACEBO-CONTROLLED TRIAL OF EFFECT OF EPTIFIBATIDE ON COMPLICATIONS OF PERCUTANEOUS CORONARY INTERVENTION - IMPACT-II
Authors: TCHENG JE LINCOFF AM SIGMON KN LEE KL KITT MM CALIFF RM TOPOL EJ JURAN N WORLEY S TUZI J HOLLYWOOD L KLEIMAN NS ALI MN ROSE D KEREIAKES DJ HIGBY N GEORGE J HEILBRUNN S RONCEVICH T BURNHEIMER B IVANHOE R MEADE L RUND M TANNENAUM M STANGLE D YAKUBOV S RUSK K FERGUSON JJ WILLERSON JT THOMAS C HARLAN M BROWNE K TELATNIK M BLANKENSHIP J DEMKO L TIMMIS G SAFIAN M RESAR J DUDEK A SPRIGGS D WAHL S GILCHRIST IC DABBS A SHADOFF N GOEBEL S MILLER M BURDICK M OWENS B MCIVOR M REDDINGER J HARTMAN C LUNOW S CONN E MCWILLIAMS C AYCOCK R WILCOX T CORBELLI J COOKE B TEIRSTEIN P HAAS G TALLEY JD RAWERT M GHALILI K MAHAFFEY T TOGGART E FOWLER P DAVIDSON C BERGELSON B SCHAECHTER A NAVETTA F BYARS S DURBIN B MUHLESTEIN JB JERMAN J NYGAARD T WHITE J SANZ M MAYER D WHITE R REATTA K AGUIRRE FV STONNER T GOTTLIEB R LAVOIE J MCDONOUGH T WESZT S MICALE P BERRY S TAYLOR M CLARK D BREWER D BLACK S ROUBIN G SUTOR C HEINSIMER J ALLAR N CRAWFORD R PIERSON M SIEGEL R VERMILLION J BENGTSON J PROCHNOW L GRIFFIN J THEODOSIOU J PARR K THOMAS L TOOLE J WISE C LERRICK K SPINAGOTTI B FRENCH W NAGELHOUT D MILLER K SEAWORTH J JENSON J COLLINS G MARK R SHEIKH K ROSNER E TENAGLIA A FRIEDMAN I WEINER B BORBONE M KUEHL W ALLEN S KRAUTHAMER D CHAIT V BELKIN R STEINBERG R CAREY D ROGERS K CATES C DAVIS D ARNOLD A SOMMERS T HERZOG W CALAMUNCI N COWFER J COHEN M LEE D SLOSKY D KACZINSKI J SIMONTON C PORTER B HINOHARA T JOHNSON M DELCORE M STANGAL L GACIOCH G CHIODO V SULLEBARGER JT FORD L KLEAVEL P FEDAK C POPMA J PRUNKA N DAVIS C FAXON D GUERCI A LOSCALZO J WEAVER WD BATTS K HUGHES D JOSEPH D KARNASH S LILLEY P LIU M MELTON J MESSICK M OWENS E PASSMORE D PULLIUM M SHAVENDER J SMITH D SMITH M SNAPP J STOSIK V SUMNER D THEL MC THOMPSON G WORKMAN J BY S CARTER J GORDON C GOTHARD P GRANGER CB HARRINGTON RA KRUSE KR MAHAFFEY KW MCCLANAHAN M MILLER M OHMAN EM PITZER L TARDIFF B WINCHELL M CROWE T DEBOWEY D GATES K STARR S WAGNER GS DAVIDSONRAY L MARK DB DUMEE C KITT M LORENZ T OBRIEN M SCARBOROUGH R SWIFT R
Citation: Je. Tcheng et al., RANDOMIZED PLACEBO-CONTROLLED TRIAL OF EFFECT OF EPTIFIBATIDE ON COMPLICATIONS OF PERCUTANEOUS CORONARY INTERVENTION - IMPACT-II, Lancet, 349(9063), 1997, pp. 1422-1428
QUANTITATIVE-EVALUATION OF LOCAL-DRUG DELIVERY USING THE INFUSASLEEVECATHETER
Authors: GOTTSAUNERWOLF M JANG YS PENN MS KAPLAN A ELLIS SG CHISOLM GM TOPOL EJ LINCOFF AM
Citation: M. Gottsaunerwolf et al., QUANTITATIVE-EVALUATION OF LOCAL-DRUG DELIVERY USING THE INFUSASLEEVECATHETER, Catheterization and cardiovascular diagnosis, 42(1), 1997, pp. 102-108
PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE AFTER CORONARY ANGIOPLASTY - REPLY/
Authors: LINCOFF AM TOPOL EJ CALIFF RM
Citation: Am. Lincoff et al., PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE AFTER CORONARY ANGIOPLASTY - REPLY/, The New England journal of medicine, 337(17), 1997, pp. 1244-1244
PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE AND LOW-DOSE HEPARINDURING PERCUTANEOUS CORONARY REVASCULARIZATION/
Authors: TOPOL EJ CALIFF RM LINCOFF AM TCHENG JE CABOT CF WEISMAN HF KEREIAKES D LAUSTEN D RUNYON JP HOWARD W KELLY T MUNCY D TIMMIS G SAFIAN M DAVEY D KLEIMAN NS ROSE D BASINGER L ROUSE C KRAMER J WILSON R TALLEY JD BOYLES M NAVETTA FI LEBUEUF R KRAFT P DVORAK L SMIGLA RM FERGUSON J HARLAN M BROWNE K TELATNIK M BLANKENSHIP J DEMKO L IVANHOE RJ JACKSON C SHADOFF N GOEBEL S TAYLOR M CLEARY E GACIOCH G CHIODO V BATES E QUAIN L SNYDER H BASS TA ROHMAN C GRADMAN A BOLTEY L TANNENBAUM M STENGL D GORDON P WRIGHT N CUMMINS F NONNWEILER J AVERSANO T PELTZER L BEAR P CRAIG MB HATTEL L TOOKE G ANDERSON HV WEIGELT L HETTLEMAN B KENNEDY S TEIRSTEIN PS CLAIRE D SAREMBOCK I SAYRE S DAVIDSON CJ SCHAECHTER A AGUIRRE F STONNER T AZRIN M BODETT J BARRY MB WORLEY S FREY LA SPRIGGS DJ WAHL SA WESTON MW YEDINAK K GEORGE B SMITH D GILLILAND C SMITH D RICCI DR FOX R HARTMAN C LUNOW S FARAH T PETRUOLO S SANDER G STEVENS A DELISE K REEN B WHISNANT D HENDERSON L HEUSER R SWIDERSKI K KALUZNIAK M LARKIN T JACKSON BJ POPMA J PRUNKA N SANZ M MAYER D MACKEY K BURTON J HOGG N BROWN R STEVENS K FRENCH W WANG S ADELMAN AG FOULGER V WEBER S GOTTLIEB R LAVOIE J KING S FRERICHS F HOLLYWOOD L DUCAS J SCHICK U HOCHMAN JS SLATER J TORMEY D ONEILL BJ FOSHAY K FITZGERALD N CHEUNG PK BEDARD D KNUDTSON ML GALBRAITH D WATT H SAMAHA J HAMILTON B KLEIN LW HEBSON L ALMOND D WHITE J ROSENBERG MJ TEULLY S UNKS M RODGERS K FAXON D GORE J KELSEY S LEE K SANE D WALTERS L BOOTH J CANNATA R CASTLE V COHEN H DELUCA S KUTNER M KNUTH T MCCOLLOUGH T MCPHERSON J MELTON J MILLER D PULLIAM M SAPP S SIGMON KN MONTAGUE E ALEXANDER K AUGOSTINI R BAJZER C BART B BELLI G CARLSON J CHALLAPALLI R CRENSHAW B DAWSON I DICKEY A ECHOLS A ERICKSON B FONTANA MB GHAFFARI S GORDON C GRANGER C GRANO G GRIMM R JOHNSON T JURAN N KINGSLEY A KRUSE K LAUER M MAHAFFEY K MALONE K MARK D MARWICK T MIGRINO R MILLER J NEWBY K PACE C PETERSON E RABBANI R RAGAN J RIMMERMAN C RODKEY S SAVOR V SHAW WF SILA C SILVER M TAN W TOBIASZ D VANDERVOORT P WANG CW WARD C WATERS J WIEHLE D WINCHELL M UNDERWOOD D CLEMONS P HEUPLER S POWERS J RUBIN D SGARBOSSA E STEINHUBL S MOLITERNO D DEBOWEY D BALAZS E CROWE T IVANC T OLS L POLISZCZUK R VILSACK H WITHERSPOON B DAVIDSONRAY L ANDERSON KM GIEL KM MUSCO MH STONER GL
Citation: Ej. Topol et al., PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE AND LOW-DOSE HEPARINDURING PERCUTANEOUS CORONARY REVASCULARIZATION/, The New England journal of medicine, 336(24), 1997, pp. 1689-1696
DURABLE INHIBITION OF ISCHEMIC COMPLICATIONS BY ABCIXIMAB DURING PERCUTANEOUS CORONARY REVASCULARIZATION - ONE-YEAR RESULTS OF THE EPILOG TRIAL
Authors: LINCOFF AM TCHENG JE ANDERSON KM CABOT CF
Citation: Am. Lincoff et al., DURABLE INHIBITION OF ISCHEMIC COMPLICATIONS BY ABCIXIMAB DURING PERCUTANEOUS CORONARY REVASCULARIZATION - ONE-YEAR RESULTS OF THE EPILOG TRIAL, Circulation, 96(8), 1997, pp. 902-902
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>